Issued Patents All Time
Showing 1–22 of 22 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12331128 | Therapeutic and diagnostic methods for cancer | Richard BOURGON, Gregg FINE, Garrett Michael Frampton, Priti HEGDE, Sanjeev Mariathasan +3 more | 2025-06-17 |
| 12194110 | PD-L1 binding polypeptides for imaging | Paul E. Morin, David J. Donnelly, Dasa Lipovsek, Jochem Gokemeijer, Maria Jure-Kunkel +6 more | 2025-01-14 |
| 11725247 | Methods of treating cancer | Garrett Michael Frampton, Roman Yelensky, James Xin Sun, Douglas B. Johnson, Christine Marie Lovly +3 more | 2023-08-15 |
| 11674962 | Therapeutic and diagnostic methods for cancer | Craig Cummings, Yan Li, Sarah Margaret SHAGAN, Erica Beth SCHLEIFMAN, David Shames +7 more | 2023-06-13 |
| 11344639 | PET imaging with PD-L1 binding polypeptides | Paul E. Morin, David J. Donnelly, Dasa Lipovsek, Jochem Gokemeijer, Maria Jure-Kunkel +7 more | 2022-05-31 |
| 11300570 | Therapeutic and diagnostic methods for cancer | Garrett Michael Frampton, Priti HEGDE, Marcin KOWANETZ, David Shames, Philip James Stephens +3 more | 2022-04-12 |
| 11279767 | Therapeutic and diagnostic methods for cancer | Richard BOURGON, Gregg FINE, Garrett Michael Frampton, Priti HEGDE, Sanjeev Mariathasan +3 more | 2022-03-22 |
| 11203630 | Serum albumin-binding fibronectin type III domains | Tracy S. Mitchell, Michael L. Gosselin, Dasa Lipovsek, Rex A. Parker, Ray Camphausen +1 more | 2021-12-21 |
| 11173219 | PD-L1 binding polypeptides for imaging | Paul E. Morin, David J. Donnelly, Dasa Lipovsek, Jochem Gokemeijer, Maria Jure-Kunkel +6 more | 2021-11-16 |
| 11149077 | Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR | Ray Camphausen, Martin C. Wright, Patrick Gage, John D. Mendlein | 2021-10-19 |
| 10934572 | Serum albumin binding molecules | Michael L. Gosselin, Joanna Swain, Tracy S. Mitchell, Ray Camphausen, Sharon Cload +4 more | 2021-03-02 |
| 10781247 | Targeted therapeutics based on engineered proteins that bind EGFR | Ray Camphausen, Brent Morse, Stuart Emanuel | 2020-09-22 |
| 10442851 | Serum albumin-binding fibronectin type III domains | Tracy S. Mitchell, Michael L. Gosselin, Dasa Lipovsek, Rex A. Parker, Ray Camphausen +1 more | 2019-10-15 |
| 10406251 | PD-L1 binding polypeptides for imaging | Paul E. Morin, David J. Donnelly, Dasa Lipovsek, Jochem Gokemeijer, Maria Jure-Kunkel +6 more | 2019-09-10 |
| 10221232 | Methods of treating cancer by administering IGF-IR binding molecules | Ray Camphausen, Martin C. Wright, Patrick Gage, John D. Mendlein | 2019-03-05 |
| 10221438 | Serum albumin binding molecules | Michael L. Gosselin, Joanna Swain, Tracy S. Mitchell, Ray Camphausen, Sharon Cload +4 more | 2019-03-05 |
| 9920108 | Targeted therapeutics based on engineered proteins that bind EGFR | Ray Camphausen, Brent Morse, Stuart Emanuel | 2018-03-20 |
| 9540424 | Serum albumin binding molecules | Michael L. Gosselin, Joanna Swain, Tracy S. Mitchell, Ray Camphausen, Sharon Cload +4 more | 2017-01-10 |
| 9234028 | Targeted therapeutics based on engineered proteins that bind EGFR | Ray Camphausen, Brent Morse, Stuart Emanuel | 2016-01-12 |
| 8969289 | Serum albumin binding molecules | Michael L. Gosselin, Joanna Swain, Tracy S. Mitchell, Ray Camphausen, Sharon Cload +4 more | 2015-03-03 |
| 8524244 | Targeted therapeutics based on engineered proteins that bind EGFR | Ray Camphausen, Brent Morse, Stuart Emanuel | 2013-09-03 |
| 8470332 | Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR | Ray Camphausen, Martin C. Wright, Patrick Gage, John D. Mendlein | 2013-06-25 |